LEADER 05368nam 2200661Ia 450 001 9910219989903321 005 20200520144314.0 010 $a1-283-59726-8 010 $a9786613909718 010 $a0-8330-3593-2 035 $a(CKB)111090529191302 035 $a(EBL)197465 035 $a(OCoLC)475901485 035 $a(SSID)ssj0000118492 035 $a(PQKBManifestationID)11145197 035 $a(PQKBTitleCode)TC0000118492 035 $a(PQKBWorkID)10051283 035 $a(PQKB)10408572 035 $a(Au-PeEL)EBL197465 035 $a(CaPaEBR)ebr10056214 035 $a(MiAaPQ)EBC197465 035 $a(EXLCZ)99111090529191302 100 $a20031112d2003 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCase studies of existing human tissue repositories $e"best practices" for a biospecimen resource for the genomic and proteomic era /$fElisa Eiseman ... [et al.] 205 $a1st ed. 210 $aSanta Monica, CA $cRAND$dc2003 215 $a1 online resource (xxxviii, 208 pages) $cillustrations, maps 300 $a"MG-120." 311 0 $a0-8330-3527-4 320 $aIncludes bibliographical references (p. 207-208). 327 $aCover; Preface; The RAND Corporation Quality Assurance Process; Contents; Figure and Tables; Summary; Acknowledgments; Abbreviations; CHAPTER ONE; Introduction; Background; National Dialogue on Cancer; RAND Study; Purpose; Description of Study; Organization of This Report; CHAPTER TWO; Methodology; Selection of Repositories; Interviews; Repositories Evaluated; Government; Academia; Industry; Repositories Not Included in the Evaluation; SPOREs; IMPATH Inc.; National Surgical Adjuvant Breast and Bowel Project (NSABP); Program for Critical Technologies in Molecular Medicine 327 $aDetermining "Best Practices" Types of Information Not Shared; CHAPTER THREE; Biospecimen Collection, Processing, Annotation, Storage, and Distribution; Biospecimen Collection; Tissue Sources; Minority Populations, Children, and Foreign Tissue Sources; Collection Locations; Biospecimen Collection; Centralized Versus Decentralized Collection and Storage; Quality Assurance, Auditing, and Standardization for Biospecimen Collection; Biospecimen Processing and Annotation; Biospecimen Processing; Tissue Characterization and Quality Control Testing of Biospecimens 327 $aData Collection and Specimen Annotation; Longitudinal Data; Quality Assurance, Auditing, and Standardization for Processing of Biospecimens; Quality Assurance, Auditing, and Standardization for Annotation of Biospecimens; Biospecimen Storage; Number and Types of Tissue in Storage; Storage Techniques; Freezer Maintenance and Backup; Quality Control, Auditing, and Standardization for Biospecimen Storage; Specimen Distribution; Shipment of Samples to Researchers; Quality Assurance and Standardization of Biospecimen Collection, Processing, Annotation, Storage, and Distribution; Best Practices 327 $aCHAPTER FOUR; Bioinformatics and Data Management; Use of Bioinformatics Systems; Types of Data Contained in Bioinformatics Systems; Data Accessibility; Bioinformatics System Security; Quality Control, Auditing, and Standardization for Bioinformatics Systems; Best Practices; CHAPTER FIVE; Consumer/User Needs; Customer Profile; Academic, Government, and Industry Users; Distribution of Samples Outside the Institution; Meeting Researcher Needs; Review and Prioritization of Requests for Tissue; Unmet User Needs; Tracking the Use of Biospecimens; Types of Research/Use of Samples 327 $aMetrics and Feedback on Repository Use; Best Practices; CHAPTER SIX; Business Plan and Operations; Government Repositories; Academic Repositories; Industry Repositories; Repository/Collection Site Relationships; Repository Operations; Lessons Learned; Repository Model; Banking Versus Prospective Collection; Centralized Versus Decentralized; Costs; Repository Costs; Costs to Researchers; Developing and Adopting New Technologies; Tracking of Sample Use; Acknowledgments in Publications; Best Practices; CHAPTER SEVEN; Privacy, Ethical Concerns, and Consent Issues; Identifiability of Tissue; Institutional Review Boards 330 $aCase studies of twelve existing human biospecimen repositories performed to evaluate their utility for genomics- and proteomics-based cancer research and to identify ?best practices? in collection, processing, annotation, storage, privacy, ethical concerns, informed consent, business plans, operations, intellectual property rights, public relations, marketing, and education that would be useful in designing a national biospecimen network. 517 3 $aHuman tissue repositories 606 $aTissue banks$vCase studies 606 $aPreservation of organs, tissues, etc$vCase studies 606 $aCadaver homografts$vCase studies 615 0$aTissue banks 615 0$aPreservation of organs, tissues, etc. 615 0$aCadaver homografts 676 $a362.17/83 701 $aEiseman$b Elisa$0899253 712 02$aRand Corporation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910219989903321 996 $aCase studies of existing human tissue repositories$92009098 997 $aUNINA